Brain Tumor Diagnosis & Therapeutics Market by Type, Indication, Distribution Channel - Global Forecast 2025-2030- Product Image

New

Brain Tumor Diagnosis & Therapeutics Market by Type, Indication, Distribution Channel - Global Forecast 2025-2030

Report
189 Pages
October 2024
Region: Global
360iResearch™
ID: 6011112

The Brain Tumor Diagnosis & Therapeutics Market grew from USD 1.63 billion in 2023 to USD 1.78 billion in 2024. It is expected to continue growing at a CAGR of 9.37%, reaching USD 3.06 billion by 2030.

The brain tumor diagnosis and therapeutics market encompasses the technologies, products, and medical processes involved in identifying and treating brain tumors, which may range from benign to malignant types. The necessity of these solutions is driven by the increasing incidence of brain tumor cases worldwide and the significant impact they have on patients' quality of life. Advances in medical imaging techniques, such as MRI and CT scans, and evolving therapeutics like surgery, radiotherapy, and chemotherapy, underscore the critical applications in early and accurate diagnosis and effective treatment. End-use sectors include hospitals, diagnostic laboratories, and research institutions, which demand both diagnostic precision and therapeutic efficacy. Key growth factors influencing this market include increasing healthcare expenditure, rising prevalence of brain cancer, technological advancements in diagnostic imaging, and enhanced drug development efforts. Recent opportunities are emerging through personalized medicine, which tailors treatment based on individual genetic profiles, and the growth of AI and machine learning for early diagnosis and treatment optimization. However, market growth is challenged by high treatment costs, the complex nature of brain tumor pathophysiology, and stringent regulatory environments for new treatments. Furthermore, side effects associated with existing therapies can limit their adoption. Innovation opportunities lie in the development of non-invasive diagnostic methods, novel therapies such as targeted therapies and immunotherapies, and precision medicine approaches. Collaborations between research institutions and biotech companies can catalyze advancements in these areas. The market is highly dynamic, characterized by continuous research and development, and heavily influenced by regulatory approvals and healthcare policies. As market players look to innovate and expand, focusing on integrating breakthrough technologies and expanding their reach in emerging markets with improved healthcare infrastructures could provide significant growth potential.

Understanding Market Dynamics in the Brain Tumor Diagnosis & Therapeutics Market

The Brain Tumor Diagnosis & Therapeutics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing prevalence of neurological disorders
- Need for tests detecting the presence of tumors
- Research activities in the molecular diagnostics
Market Restraints
- High cost associated with the diagnosis and treatment
Market Opportunities
- Rising healthcare expenditure and the favorable reimbursement policies
- Government initiatives for cancer awareness
Market Challenges
- Side effects associated with brain tumor therapeutics

Exploring Porter’s Five Forces for the Brain Tumor Diagnosis & Therapeutics Market

Porter’s Five Forces framework further strengthens the insights of the Brain Tumor Diagnosis & Therapeutics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Brain Tumor Diagnosis & Therapeutics Market

External macro-environmental factors deeply influence the performance of the Brain Tumor Diagnosis & Therapeutics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Brain Tumor Diagnosis & Therapeutics Market

The Brain Tumor Diagnosis & Therapeutics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Brain Tumor Diagnosis & Therapeutics Market

The Brain Tumor Diagnosis & Therapeutics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Brain Tumor Diagnosis & Therapeutics Market

The Brain Tumor Diagnosis & Therapeutics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brain Tumor Diagnosis & Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Co, Carestream Health, Inc., Eisai Co., Ltd., F. Hoffmann-La Roche AG, Fujifilm Corporation, GE Healthcare Inc., GlaxoSmithKline PLC, Hologic, Inc., Illumina, Inc., Invitae Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Merck & Co. Inc., NantOmics, NeoGenomics Laboratories, Inc., Novartis AG, Oncologica Limited, Pfizer, Inc., S&P Global Inc., Shimadzu Corporation, and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the Brain Tumor Diagnosis & Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Diagnosis
  - Cerebral Arteriogram
  - CT Scan
  - EEG
  - Lumbar Puncture
  - Molecular Testing
  - MRI
  - PET-CT Scan
  - Tissue Sampling
- Therapeutics
  - Chemotherapy
  - Immunotherapy
  - Radiation Therapy
  - Surgery
  - Targeted Therapy
Indication
- Glioblastoma
- Meningioma
- Pituitary Tumors
Distribution Channel
- Offline
  - Diagnostic Centers
  - Hospital & Clinics
  - Retail Pharmacies
- Online

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of neurological disorders
5.1.1.2. Need for tests detecting the presence of tumors
5.1.1.3. Research activities in the molecular diagnostics
5.1.2. Restraints
5.1.2.1. High cost associated with the diagnosis and treatment
5.1.3. Opportunities
5.1.3.1. Rising healthcare expenditure and the favorable reimbursement policies
5.1.3.2. Government initiatives for cancer awareness
5.1.4. Challenges
5.1.4.1. Side effects associated with brain tumor therapeutics
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Brain Tumor Diagnosis & Therapeutics Market, by Type

6.1. Introduction
6.2. Diagnosis
6.2.1. Cerebral Arteriogram
6.2.2. CT Scan
6.2.3. EEG
6.2.4. Lumbar Puncture
6.2.5. Molecular Testing
6.2.6. MRI
6.2.7. PET-CT Scan
6.2.8. Tissue Sampling
6.3. Therapeutics
6.3.1. Chemotherapy
6.3.2. Immunotherapy
6.3.3. Radiation Therapy
6.3.4. Surgery
6.3.5. Targeted Therapy

7. Brain Tumor Diagnosis & Therapeutics Market, by Indication

7.1. Introduction
7.2. Glioblastoma
7.3. Meningioma
7.4. Pituitary Tumors

8. Brain Tumor Diagnosis & Therapeutics Market, by Distribution Channel

8.1. Introduction
8.2. Offline
8.2.1. Diagnostic Centers
8.2.2. Hospital & Clinics
8.2.3. Retail Pharmacies
8.3. Online

9. Americas Brain Tumor Diagnosis & Therapeutics Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Brain Tumor Diagnosis & Therapeutics Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Brain Tumor Diagnosis & Therapeutics Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

LIST OF FIGURES

FIGURE 1. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET DYNAMICS
TABLE 7. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CEREBRAL ARTERIOGRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY EEG, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY PET-CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TISSUE SAMPLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MENINGIOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY PITUITARY TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 55. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 57. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 58. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 63. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 64. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 87. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 89. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 90. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 93. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 95. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 96. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 105. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 107. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 108. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 121. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 141. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 143. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 144. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 160. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 162. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 163. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 166. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 168. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 169. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 170. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 172. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 174. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 175. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 178. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 180. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 181. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 184. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 186. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 187. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 188. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 194. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 196. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 198. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 199. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 200. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 214. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 216. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 217. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 218. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 220. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 222. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 223. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 226. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 227. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 228. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 229. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 230. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 250. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 251. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 252. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 253. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 254. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 268. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 269. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 270. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 271. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 272. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 284. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 286. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 287. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Brain Tumor Diagnosis & Therapeutics market, which are profiled in this report, include:

Abbott Laboratories
AstraZeneca PLC
Bayer AG
Bristol-Myers Squibb Co
Carestream Health, Inc.
Eisai Co., Ltd.
F. Hoffmann-La Roche AG
Fujifilm Corporation
GE Healthcare Inc.
GlaxoSmithKline PLC
Hologic, Inc.
Illumina, Inc.
Invitae Corporation
Johnson & Johnson Services, Inc.
Koninklijke Philips N.V.
Merck & Co. Inc.
NantOmics
NeoGenomics Laboratories, Inc.
Novartis AG
Oncologica Limited
Pfizer, Inc.
S&P Global Inc.
Shimadzu Corporation
Siemens Healthineers AG

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	189
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.78 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.06 Billion
Compound Annual Growth Rate	9.3%
Regions Covered	Global
No. of Companies Mentioned	24

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3761EUR$3,939USD£3,131GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6655EUR$6,969USD£5,539GBP

Understanding Market Dynamics in the Brain Tumor Diagnosis & Therapeutics Market

Exploring Porter’s Five Forces for the Brain Tumor Diagnosis & Therapeutics Market

Applying PESTLE Analysis to the Brain Tumor Diagnosis & Therapeutics Market

Analyzing Market Share in the Brain Tumor Diagnosis & Therapeutics Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Brain Tumor Diagnosis & Therapeutics Market

Strategic Recommendations for Success in the Brain Tumor Diagnosis & Therapeutics Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Brain & Spinal Cord Cancer Market by Tumor Type (Glioblastoma, Meningioma, Pituitary Tumors), Treatment (Diagnosis, Therapeutics), End-users - Forecast 2024-2030

Brain Tumor Diagnosis and Therapeutics Market Size, Share and Trends Analysis Report by Type, Product (Stains & Varnishes, Shellacs), Diagnosis, Therapeutics, End-use, and Region 2024-2030

Brain Tumor Therapeutics Market by Type, Therapy, Patient Age Group, Distribution Channel, End-User - Global Forecast 2025-2030

Brain Tumor Diagnosis & Treatment Market by Treatment, Diagnosis, Type - Global Forecast 2025-2030

Glioma - Market Insight, Epidemiology And Market Forecast - 2032

About the Brain Tumor Drug Market